新一代驱虫抗生素—莫西菌素

莫西菌素同伊维菌素一样 ,是一种目前广泛用于兽医临床的广谱、高效、新型大环内酯类驱虫抗生素 ,是美贝霉素家族中的一员。由于其独特的理化性质 ,在国外 ,已被广泛用于治疗奶牛、猪等动物体内外寄生虫病。文章对莫西菌素的理化特性、作用机制、药动学、制剂、药效、耐药性、毒性、残留等进行了较详细地综述 ,同时也介绍了减少耐药性产生的一些方法 ,为该药能在国内应用提供第一手资料 ,以求为兽医临床用药提供参考     

Amoxicillin—current use in swine medicine

Amoxicillin has become a major antimicrobial substance in pig medicine for the treatment and control of severe, systemic infections such as Streptococcus suis. The minimum inhibitory concentration 90% (MIC 90) is 0.06 μg amoxicillin/ml, and the proposed epidemiological cut‐off value (ECOFF) is 0.5 μg/ml, giving only 0.7% of isolates above the ECOFF or of reduced susceptibility. Clinical breakpoints have not been set for amoxicillin against porcine pathogens yet, hence the use of ECOFFs. It has also been successfully used for bacterial respiratory infections caused by Actinobacillus pleuropneumoniae and Pasteurella multocida. The ECOFF for amoxicillin against A. pleuropneumoniae is also 0.5 μg/ml demonstrating only a reduced susceptibility in 11.3% of isolates. Similarly, P. multocida had an ECOFF of 1.0 μg/ml and a reduced susceptibility in only 2.6% of isolates. This reduced susceptibility disappears when combined with the beta‐lactamase inhibitor, clavulanic acid, demonstrating that it is primarily associated with beta‐lactamase production. In contrast, amoxicillin is active against Escherichia coli and Salmonella species but using ECOFFs of 8.0 and 4.0 μg/ml, respectively, reduced susceptibility can be seen in 70.9% and 67.7% of isolates. These high levels of reduced susceptibility are primarily due to beta‐lactamase production also, and most of this resistance can be overcome by the combination of amoxicillin with clavulanic acid. Currently, amoxicillin alone is considered an extremely valuable antimicrobial in both human and animal medicine and remains in the critically important category of antibiotics alongside the fluoroquinolones and macrolides by the World Health Organization as well as the third‐ and fourth‐generation cephalosporins, but these cephalosporins show marked resistance to basic beta‐lactamase production and are only destroyed by the extended‐spectrum beta‐lactamases. Amoxicillin alone and in combination with clavulanic acid are currently classed together in Category 2 in the European Union. By reviewing the pharmacodynamic data and comparing this with pharmacokinetic data from healthy and infected animals and clinical trial data, it can be seen that the product has a good efficacy against S. suis and A. pleuropneumoniae, in spite of usage over many years. However, it may be much less efficacious on its own against E. coli, due to reduced susceptibility and resistance associated with beta‐lactamase production, which is largely overcome by the use of clavulanic acid. It is felt that this differentiation may be useful in future classification of amoxicillin alone, in comparison with its combined use with clavulanic acid and thereby preserve the use of the more critically important antibiotics in veterinary medicine and reducing the risk of their resistance being transmitted to human.     

新型莫西菌素浇泼剂对羊蜱蝇和消化道线虫驱虫药效评价

试验旨在通过新型莫西菌素（moxidectin,MOX）浇泼剂对羊的驱虫试验,评价MOX浇泼剂对羊蜱蝇和消化道线虫的临床药效。将150只阿勒泰羊经产母羊随机分为6组,每组25只,分别为不用药对照组、螨净药浴组、MOX注射组和MOX低（0.05 mL/（kg·BW））、中（0.1 mL/（kg·BW））和高（0.2 mL/（kg·BW））剂量浇泼组,试验期为1周。试验第1天按前述分组中方法和剂量驱虫1次。观察受试动物临床表现,测定给药前1天和给药后第7天体温、脉搏和呼吸（TPR）,血液生理、生化和尿常规指标;测定羊蜱蝇减虫率、治愈率。采取粪样测定消化道线虫每克粪中虫卵个数（EPG）减少率及转阴率。结果显示,与不用药对照组相比,给药后第7天各驱虫组TPR、血液生理、生化及尿常规指标均无显著差异（P>0.05）。螨净药浴组羊蜱蝇减虫率为43.7%,而MOX注射组及MOX低、中、高剂量浇泼组均为100%。螨净药浴组治愈率为13.0%,而MOX注射组及MOX低、中、高剂量浇泼组均为100%;与不用药对照组相比,螨净药浴组消化道线虫卵减少率为0,而MOX注射组及MOX低、中、高剂量浇泼组分别为91.6%、93.1%、94.9%和97.8%。螨净药浴组虫卵转阴率为0,而MOX注射组及MOX低、中、高剂量浇泼组分别为77.0%、69.2%、69.2%和84.6%。本试验结果表明,新型MOX浇泼剂对体外寄生虫和消化道线虫均有显著疗效,且优于螨净药浴,与MOX注射剂等效。实践应用中最适MOX浇泼剂量推荐为0.05 mL/（kg·BW）（即0.25 mg/（kg·BW））。     

迷迭香的药效及在兽医临床的应用

迷迭香为唇形科植物,喜温,原产地中海沿岸,广泛用于医药、油炸食品及各类油脂的保鲜。研究表明,迷迭香具有抗炎、抗氧化、抗菌、抗癌、护肝等药效作用,在兽医临床可能有广泛的应用前景。通过查阅国内外有关文献资料,综述了迷迭香药效和兽医临床应用的进展,为迷迭香的进一步研究提供参考。     

氟甲砜霉素对鸭疫里氏杆菌病的药效学研究

以试管二倍稀释法测定了氟甲砜霉素、氯霉素、红霉素、林可霉素、SMZ、氟哌酸对鸭疫里氏杆菌的体外最小抑菌浓度88.1为1μg/mL、2μg/mL、4μg/mL、32μg/mL、64μg/mL、8μg/mL。180只健康本地麻鸭分成6组,每组30只,除1组作健康对照外,其它5组按2.5mL/kg.bw皮下注射鸭疫里氏杆菌培养物(3.8×109cfu/mL)。感染鸭用氟甲砜霉素内服治疗,给药剂量分别为30mg/kg、20mg/kg、10mg/kg,以氯霉素作对照(30mg/kg),1d1次,连续用药3d,给药结束15d后,各治疗组的治愈率为93.3%,90.0%,80.7%和82.1%,感染对照组死亡率为56.7%。     

金莲花植物成分及其药剂的研究进展

综述了金莲花的植物学及植物化学、成分分析、药理作用、临床应用及制剂等方面的研究状况，并对目前研究存在的问题及以后的发展前景进行了讨论。     

丹参注射液实验性药效作用

实验结果表明,丹参注射液分别在3×10~(-3)g/ml和6×10~(-3)g/ml浓度时,小白鼠子宫活动呈轻度弛缓,记录图形波谷略下延,收缩间隔延长,子宫活动较用药前有明显差别(P<0.05);妊娠小白鼠每只一次皮下注射0.2 mI丹参注射液,每日1次,连续3次,试期无一例发生流产,妊娠鼠均产下健康乳鼠;用妊娠山羊作同样实验(山羊体重30kg左右,每次每只皮下注射10ml丹参液,约含生药10g,每日1次,连续3次),同样无一例发生流产,妊娠期满顺利产下健康羊羔;丹参注射液离体兔耳灌流后,兔耳皮肤血管短暂徼弱扩张,但用药前后流量变化差异不明显(P>0.05)。     

头孢噻呋对实验性感染鸡白痢沙门氏菌病的药效学研究

研究了头孢噻呋对实验性感染鸡白痢沙门氏菌的防治效果。结果显示，头孢噻呋体内疗效良好，治疗组与预防组的治愈率、有效率、相对增重率均不同程度高于感染对照组（P〈0.05或P〈0.01）；头孢噻呋的治疗效果高剂量组与中剂量组无显著差异（P〉0．05），高剂量组与低剂量组差异显著（P〈0．05）；头孢噻呋的中剂量组与头孢曲松、氨苄西林组的疗效相比均差异显著（P〈0．05或P〈0．01）。实验结果表明，头孢噻呋按0．1mg／只的剂量肌肉注射，每日一次，可对鸡白痢沙门氏菌病起到有效的防治效果。     

几种杀菌剂对南方红豆杉炭疽病的田间药效测定

在田间药效测定中,喷雾和注干两种施药方法相比,喷雾防治的效果明显好于注干的防治效果。喷雾试验中,防治效果最好的是甲基托布津,平均防治效果达到78.79%,最差的是退菌特,平均防治效果为57.20%;在注干防治试验中,防治效果最好的依然为甲基托布津,为62.50%,其次为炭克、多菌灵,最差的为退菌特,为46.57%。     

兽用抗寄生虫药莫奈太尔的研究进展

概述了一种新型氨基乙腈衍生物类驱虫药莫奈太尔的理化性质、作用机制、药代动力学、药效学等特点,以期为该药在兽医临床应用提供参考。